Clinical Trials Browser

Phase 1/2 × Dexrazoxane × Clear all

NCT00098839 2017-12-12

Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL)

Phase 1/2 Completed

134 enrolled 13 charts

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01596088 2015-04-07

A Phase I/II Study of KDX-0811(Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracycline Anti-cancer Agents

Phase 1/2 Completed

2 enrolled 6 charts

Extravasations of Anthracycline Anti-cancer Agents